Furthermore, to investigate the molecular effect of ANRIL inhibition on the cisplatin-sensitivity of ovarian cancer cells, we also demonstrated that HMGA2 is the target gene of let-7a, and silencing ANRIL led to elevated let-7a but declined HMGA2, but inhibiting let-7a gave rise to the contrary results. Here, CDKN2B-AS1 is linked to ovarian cancer.